Risk factors of developing critical conditions in Iranian patients with COVID-19.
COVID-19
Coronavirus
Management
Mortality
Journal
Global epidemiology
ISSN: 2590-1133
Titre abrégé: Glob Epidemiol
Pays: United States
ID NLM: 101759263
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
13
11
2020
revised:
04
12
2020
accepted:
04
12
2020
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
ppublish
Résumé
COVID-19 due to novel Coronavirus was first reported in Wuhan, China. Nowadays, the Islamic Republic of Iran stands among countries with high COVID-19 prevalence and high burden of disease. Since the medical resources are limited, we aimed to identify the risk factors for patients developing critical conditions. This can help to improve resource management and treatment outcomes. In this retrospective study, we included 12,677 patients who were from 26 hospitals, supervised by Tehran University of Medical Sciences with signs and symptoms of COVID-19, until April 12. University integrated IT system was adopted to collect the data. We performed Logistic regression to evaluate the association between death in COVID-19 positive patients and other variables. Cough, respiratory distress and fever were the most common symptoms in our patients, respectively. Cancer, chronic lung diseases and chronic neurologic diseases were the strongest risk factors for death in COVID-19 patients.
Identifiants
pubmed: 33521624
doi: 10.1016/j.gloepi.2020.100046
pii: S2590-1133(20)30030-4
pmc: PMC7833422
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100046Informations de copyright
© 2020 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Mohammad Ali Mansournia is a Senior Associate Editor on Global Epidemiology. Authors declare no conflict of interests in performing this research.
Références
Trends Mol Med. 2020 May;26(5):483-495
pubmed: 32359479
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
BMJ. 2016 Apr 27;352:i1981
pubmed: 27121591
Trop Dis Travel Med Vaccines. 2020 Aug 28;6:16
pubmed: 32868984
J Clin Virol. 2020 Jun;127:104357
pubmed: 32305884
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Eur Respir J. 2020 Apr 23;55(4):
pubmed: 32139464
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244365
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Healthc Qual Res. 2021 Jan-Feb;36(1):47-51
pubmed: 33162382
JAMA. 2020 Apr 14;323(14):1339-1340
pubmed: 32108857
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Ann Intern Med. 2021 Jan;174(1):125-127
pubmed: 32687717
SN Compr Clin Med. 2020;2(10):1740-1749
pubmed: 32904541
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
Glob Epidemiol. 2020 Nov;2:100035
pubmed: 33015615
J Neurol. 2021 Jan;268(1):240-247
pubmed: 32770412
Emerg Infect Dis. 2021 Feb;27(2):636-638
pubmed: 33349310
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
Discoveries (Craiova). 2020 Apr 26;8(2):e108
pubmed: 32377559
Am J Epidemiol. 2018 Apr 1;187(4):864-870
pubmed: 29020135
Epidemiol Infect. 2020 Nov 13;148:e300
pubmed: 33183367
PLoS One. 2020 Sep 3;15(9):e0234452
pubmed: 32881860
Int J Biol Sci. 2020 Mar 15;16(10):1698-1707
pubmed: 32226287
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Travel Med Infect Dis. 2020 Jul - Aug;36:101607
pubmed: 32112857
Curr HIV Res. 2020;18(5):373-380
pubmed: 32652912
N Engl J Med. 2020 Apr 9;382(15):1476-1478
pubmed: 32163698
Med Sci Monit. 2020 Sep 04;26:e927212
pubmed: 32883943
Cell. 2018 Mar 8;172(6):1157-1159
pubmed: 29522735
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
EClinicalMedicine. 2020 Aug;25:100449
pubmed: 32838231
Stat Med. 2015 Oct 15;34(23):3133-43
pubmed: 26011599
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930